https://www.selleckchem.com/pr....oducts/Tigecycline.h
mended in major US and European guidelines according to CKD measures, when available. US National Kidney Foundation and the NIDDK. US National Kidney Foundation and the NIDDK. Male patients with breast cancer (BrC) have increased risk of developing 2nd-primary BrC (2nd-BrC). Given the relative rarity of male BrC, population-based registries are needed to analyze overall survival (OS) outcomes for these patients. Using the Surveillance, Epidemiology and End Results registry of patients diagnosed from 1975 to 2016, a cohort study of m
Like
Comment
Share
